The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2019

Filed:

Nov. 27, 2017
Applicant:

Novartis Ag, Basel, CH;

Inventors:

Bernhard Hubert Geierstanger, Solana Beach, CA (US);

Jan Grunewald, San Diego, CA (US);

Weijia Ou, San Diego, CA (US);

Shifeng Pan, San Diego, CA (US);

Tetsuo Uno, San Diego, CA (US);

Yongqin Wan, San Diego, CA (US);

Xing Wang, San Diego, CA (US);

Assignee:

Novartis AG, Basel, CH;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 207/09 (2006.01); C07K 5/02 (2006.01); A61K 47/68 (2017.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 413/12 (2006.01); C07K 16/32 (2006.01);
U.S. Cl.
CPC ...
C07D 207/09 (2013.01); A61K 47/6803 (2017.08); A61K 47/6849 (2017.08); A61K 47/6851 (2017.08); A61K 47/6855 (2017.08); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 413/12 (2013.01); C07K 5/0205 (2013.01); C07K 16/32 (2013.01);
Abstract

Disclosed herein are novel compounds of formula (I) as described herein: and the use of such peptides in making immunoconjugates (i.e Antibody Drug Conjugates) Also described herein are immunoconjugates (i.e Antibody Drug Conjugates) comprising such novel compound linked to an antigen binding moiety, such as an antibody; where such immunoconjugates are useful for treating cell proliferative disorders. The invention further provides pharmaceutical compositions comprising these immunoconjugates, compositions comprising the immunoconjugates with a therapeutic co-agent, and methods to use these immunoconjugates and compositions for treating cell proliferation disorders.


Find Patent Forward Citations

Loading…